Relay Medical Announces Closing of Private Placement for Proceeds of Over $1.5M
Toronto, Ontario--(Newsfile Corp. - May 17, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the closing of a private placement financing (the "Offering") for gross proceeds of $1,532,500 through the issuance of 7,662,500 Units (each, a "Unit") at a price of $0.20 per unit. Each Unit is comprised of: (i) one common share in the capital of the Company (each a "Common Share"); (ii) one Common...
2019-05-17 5:00 PM EDT
Relay Medical Commences Second Pharmatrac User Study and Reports on Development Activities
Toronto, Ontario--(Newsfile Corp. - May 16, 2019) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, reports on Pharmatrac development activities and the commencement of a user study on the Pharmatrac in-home countertop medication appliance. In early February the Company reported on the Pharmatrac digital medication label hardware design following the completion of the first Relay-led user study. Following further business...
2019-05-16 4:05 PM EDT
Relay Medical Reports on Technical Advancement of HemoPalm System
Toronto, Ontario--(Newsfile Corp. - May 14, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on technical advances of the Company's enhanced HemoPalm point-of-care (POC) testing platform. Development Highlights: Demonstrated feasibility of whole blood analysis: The Company's proprietary optical approach has demonstrated accurate measurement of hemoglobin fractions (compared with...
2019-05-14 4:05 PM EDT
Relay Medical Strengthens Board of Directors with Established Software, Financial and Pharma Executives
Toronto, Ontario--(Newsfile Corp. - April 1, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce Messrs. Sid Thomas, Medhanie Tekeste and Greg Van Staveren as new appointments to the Company's Board of Directors. The appointments are effective immediately. These appointments are consistent with the Company's expansion and advancement as an integrated MedTech innovator developing technologies for...
2019-04-01 2:55 AM EDT
Paul Glavina Joins Relay Medical and HemoPalm Team as Vice President, In Vitro Diagnostics
Toronto, Ontario--(Newsfile Corp. - February 13, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) (“Relay” or the “Company”), an engine of MedTech innovation, is pleased to announce the appointment of Paul Glavina as Vice President, In Vitro Diagnostics, of Relay Medical Corp. Paul is a veteran leader of more than 30 years in the application of biosensors at the point of patient care (“Point of Care Testing”, POCT). As Relay’s Vice President, In Vitro Diagnostics (IVDs), he...
2019-02-13 3:00 AM EST
Relay Medical Announces Pharmatrac Digital Label Design and Development Activities
Toronto, Ontario--(Newsfile Corp. - February 11, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on development activities and hardware design on the Pharmatrac medication management technology. Following the completion of the first Relay led Pharmatrac user study, the Company is pleased to present the Pharmatrac's digital label hardware design. In November 2018 the Company announced the...
2019-02-11 4:10 PM EST
Relay Medical Reports Progress on Enhanced HemoPalm System Design and Provides Update on Product Development and Market Advancement Activities
Toronto, Ontario--(Newsfile Corp. - February 7, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on the advancement of the Company's HemoPalm technology and Relay's enhanced HemoPalm system design as well as market advancement activities as the Company continues to build toward productization of this unique point-of-care (POC) testing platform. Relay is developing the HemoPalm technology to...
2019-02-07 2:55 AM EST
Relay Medical Provides 2018 Overview
Toronto, Ontario--(Newsfile Corp. - February 4, 2019) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to provide an overview of operations and developments for 2018. In 2018 Relay Medical made significant advances to the company's business and capabilities, notably changing the leadership, defining and refining the business model, expanding the techno-commercial team, building relevant infrastructure,...
2019-02-04 2:55 AM EST
Relay Medical Appoints Executives; John Soloninka Appointed Senior Vice-President, Acquisitions and Exits; Yoav Raiter as Director, Product Development
Toronto, Ontario--(Newsfile Corp. - December 13, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the appointment of John Soloninka as Senior Vice-President of Acquisitions and Exits and Yoav Raiter as Director of Product Development. The appointments have been made in support of the Company's multi-project integrated accelerator model. John Soloninka is a seasoned MedTech executive with over...
2018-12-13 4:05 PM EST
Relay Medical Commences User Studies on Pharmatrac Medication Management Technology
Toronto, Ontario--(Newsfile Corp. - November 20, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the commencement of user studies on the Company's wholly-owned Pharmatrac medication management technology. In conjunction, Relay Medical has engaged the research and systems design firm Human Factors North Inc. (HFN) to design and manage the Toronto, Ontario based user studies. The user study is...
2018-11-20 4:29 PM EST
Relay Medical Introduces the Pharmatrac Technology and Reports on Development
Toronto, Ontario--(Newsfile Corp. - November 15, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to introduce the Company's Pharmatrac Technology and report on related development activities. The Pharmatrac is a UX-centric (user experience) system designed to improve management and identification of medications. The Pharmatrac technology was acquired as part of Relay's recent acquisition of the Ottawa...
2018-11-15 3:05 AM EST
Relay Medical Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - November 13, 2018) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to report on two propriety software developments and the expansion of the Company's headquarters and development facilities. The software developments include a cloud-based regulatory management system and a modular software development toolkit for rapid prototyping and proprietary development. Relay's...
2018-11-13 3:05 AM EST
Relay Medical To Commence Trading in United States as RYMDF
Toronto, Ontario--(Newsfile Corp. - September 24, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to provide an update on the Company's trading status in the United States. On September 25, 2018, Relay Medical will commence trading on the OTC:QB market under the symbol RYMDF. Relay currently trades on the Canadian Securities Exchange in Canada as RELA and in Europe under the symbol EIY2. For further...
2018-09-24 9:58 PM EDT
Relay Medical Signs Term Sheet for New Product Acquisition
Toronto, Ontario--(Newsfile Corp. - August 23, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: CHXIF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the signing of a term sheet to acquire a gynecological clinical invention. The invention addresses postoperative gynecological complications and is intended to address a clear clinical need and a very large market. This acquisition represents an opportunity for product development in-line with...
2018-08-23 4:05 PM EDT
Letter from Lahav Gil, Relay Medical CEO
Toronto, Ontario--(Newsfile Corp. - August 8, 2018) - Relay Medical Corp. (the "Company" or "Relay") (CSE: RELA) (OTC: CHXIF) (FSE: EIY2) (WKN: A2JQR0) is pleased to release the following letter from Lahav Gil, Company CEO. From the desk of Lahav Gil, Chief Executive Officer, Relay Medical Corp.: Dear Shareholders, As we enter this new phase in business expansion, I would like to take this opportunity to address our shareholders, supporters and the investing public at large, to provide...
2018-08-08 4:08 PM EDT
Relay Medical Announces Completion of Private Placement Raising Aggregate Gross Proceeds of $2,251,200.44
Toronto, Ontario--(Newsfile Corp. - August 3, 2018) - Relay Medical Corp. ("Relay" or the "Company") (CSE: RELA) (OTCQB: CHXIF) (FSE: EIY2), a developer of MedTech innovation, is pleased to announce that the Company has completed the second and final tranche (the "Second Tranche") of the placement offering (the "Offering") for gross proceeds of $640,000.76 through the issuance of 2,782,612 units (each, a "Unit") at a price of $0.23 per Unit. The aggregate gross proceeds raised pursuant to the...
2018-08-03 4:05 PM EDT
Relay Medical Provides HemoPalm Update
Toronto, Ontario--(Newsfile Corp. - August 3, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: CHXIF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to provide an update on recent development activities related to the Company's HemoPalm product. In early January 2018, Lahav Gil was appointed Chief Executive Officer. Lahav has since led the expansion of the Company's development infrastructure and techno-commercial team to conduct thorough market research...
2018-08-03 3:00 AM EDT
Relay Medical Announces Closing of Private Placement for Proceeds of Over $1.6M
Toronto, Ontario--(Newsfile Corp. - July 27, 2018) - Relay Medical Corp. (CSE: RELA) (OTCQB: CHXIF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce that the Company has closed a private placement offering (the "Offering") for gross proceeds of $1,611,199.68 through the issuance of 7,005,216 units (each, a "Unit") at a price of $0.23 per Unit. Each Unit is comprised of: (i) one common share in the capital of the Company (a "Common Share"); (ii)...
2018-07-27 4:05 PM EDT
ChroMedX Announces Results of Annual General Meeting and Name Change
Toronto, Ontario--(Newsfile Corp. - July 4, 2018) - ChroMedX Corp., (CSE: CHX) (OTCQB: CHXIF) (FSE: EIY2) (the "Company"), developer of the HemoPalm Handheld Blood Analyzer Platform, is pleased to announce the results of the annual general meeting held on June 29, 2018. All matters presented to the shareholders were approved including the change of the Company's name to Relay Medical Corp. In accordance with the Company's expansion into an integrated Medtech accelerator/incubator, as...
2018-07-04 4:54 PM EDT
ChroMedX Appoints Tom Glawdel as Chief Scientific Officer and HemoPalm Science Lead
Toronto, Ontario--(Newsfile Corp. - June 20, 2018) - ChroMedX Corp. (CSE: CHX) (OTCQB: CHXIF) (FSE: EIY2) (the "Company"), developer of the HemoPalm Handheld Blood Analyzer Platform, is pleased to announce the appointment of Tom Glawdel, PhD as Chief Scientific Officer and HemoPalm science lead effective immediately. Mr. Glawdel is a decorated PhD in Mechanical and Mechatronics Engineering from the University of Waterloo with experience in the development of microfluidic, molecular...
2018-06-20 4:10 PM EDT